Kininogen deficiency modulates chronic intestinal inflammation in genetically susceptible rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 283, Issue 1 46-1, 2002, Pages

  Isordia Salas, Irma ^a   Pixley, Robin A ^a   Li, Fengling ^b   Sainz, Irma ^a   Balfour Sartor, R ^b   Adam, Albert ^c   Colman, Robert W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Contact system; Experimental colitis; Inflammatory bowel disease; Kallikreinkinin system

Indexed keywords

KALLIKREIN; KININ; KININOGEN; PEPTIDOGLYCAN POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC GRANULOMATOUS DISEASE; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENTEROCOLITIS; FEMALE; GENETIC CROSS; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; KALLIKREIN KININ SYSTEM; LEUKOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SCORING SYSTEM;

EID: 0036081625     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00514.2001     Document Type: Article

References (35)

1. Quantification of rat T-kininogen using immunological methods. Application to inflammatory processes
2. Bioregulation of kinins: Kallikreins, kininogens, and kininases
3. Endogenous kinins are involved in the pathogenesis of peptidoglycan-induced arthritis in the Lewis rat
4. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways
5. Recombinant tumor necrosis factor receptor p75 fusion protein (TNRF: Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans
6. Evaluation of a microassay for human plasma prekallikrein
7. Contact activation pathway, inflammation and coagulation
8. The activation of the alternative pathway C3 convertase by human plasma kallikrein
9. Experimental models of inflammatory bowel disease
10. Inflammatory bowel disease: Etiology and pathogenesis
11. Kinins as mediators of intestinal secretion
12. Activation of the classical pathway of complement by Hageman factor fragment
13. A point mutation of Alanine 163 to Threonine is responsible for the defective secretion of high molecular weight kininogen by the liver of rat Brown Norway Katholiek rats
14. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers
15. The activation of prourokinase by plasma kallikrein and its inactivation by thrombin
16. A prealbumin activator of prekallikrein. III. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein
17. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats
18. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins)
19. The partial thromboplastin time with kaolin: A simple screening test for first stage plasma clotting factor deficiencies
20. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease
21. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments
22. Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis
23. Purified human plasma kallikrein aggregates human blood neutrophils
24. Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans
25. Function and immunohistochemistry of prekallikrein high molecular weight kininogen complexes in plasma
26. Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function
27. Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat
28. Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats
29. Kallikrein-kinin system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats
30. Mucosal immunoregulation and inflammatory bowel disease: New insights from murine models of inflammation
31. Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII)
32. Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan induced acute arthritis in the Lewis rat
33. Purified plasma factor FXIIa aggregates human neutrophils and causes degranulation
34. Mucosal injury and inflammation in a model of chronic granulomatous colitis
35. Purified human plasma kallikrein does not stimulate but primers neutrophils for superoxide production